Based on the median value of COL22A1 mRNA levels in GBM tissues, the 40 patients were categorized into high- and low-COL22A1 expression groups, with 20 patients showing high expression above the median value and 20 patients showing low expression below the median value. The gene discussed is COL22A1; the disease is glioblastoma.